The Filing Desk

Regenxbio vs Xencor

Regenxbio RGNX · Xencor XNCR · Biotechnology

Regenxbio reported revenue of $170 million in fiscal 2025, 1.4 times Xencor's $126 million in fiscal 2025. Regenxbio's revenue grew 104.5% in its latest year, and Xencor's grew 13.7%. Regenxbio had an operating margin of -94.6%, against -141.3% at Xencor. Free cash flow was −$126 million at Regenxbio and −$138 million at Xencor.

Side by side

RegenxbioXencor
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$170M$126M
Revenue growth104.5%13.7%
Revenue growth a year, last 5 years2.0%0.5%
Gross margin——
Operating margin−94.6%−141.3%
Net margin−113.8%−73.2%
Free cash flow−$126M−$138M
Free cash flow margin−74.2%−110.1%
Return on capital—−19.9%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count4.2%14.1%
Last close$7.64$37.09
P/E at the last close——
Insider trades, last 12 months—sold $7.4 million
Piotroski F-score—3 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
RegenxbioXencor
Operating margin
Percent of revenue
RegenxbioXencor
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
RegenxbioXencor

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Regenxbio and Xencor pages.